Corpusense

Thermo Fisher Scientific (TMO) earnings call transcript summary & sentiment

Last call Thu 23 Jul 2026·Next Wed 21 Oct 2026

Our read on the 23 July 2026 earnings call

Overall tone: Positive

Overall tone

Positive

Executive Summary

Thermo Fisher Scientific delivered strong second-quarter 2026 financial results, generating 10% reported revenue growth to $11.99 billion, 5% organic revenue growth, and a 13% increase in adjusted EPS to $6.03.

Core Signals

Revenue Growth & Demand: Reported Q2 revenue grew 10% to $11.99 billion with organic growth accelerating to 5%, backed by strengthening customer activity across all major end markets.

Q&A Signals

Repeated analyst topics: Analysts focused heavily on second-half organic growth phasing, pharma/biotech spending momentum, clinical research/PPD authorization strength, and drivers behind Analytical Instruments outperformance.

Key Investor Debate

Investors are debating whether second-half organic revenue acceleration to 4% relies too heavily on broad biotech funding recovery versus core market share gains in instruments and bioproduction.

Analyst Takeaway

Thermo Fisher presented a clean quarter beat-and-raise, confirming that core end markets—notably pharma, biotech, and industrial—are strengthening after prior choppy periods.

Those are the opening lines. The full read covers the whole earnings transcript: every bullish and bearish signal, what analysts pressed hardest on, and where management answered vaguely — each with the quote behind it. Every line sourced.

See the full Earnings Highlight

Themes across Thermo Fisher Scientific and the Health Care sector

Analyse a theme over quarters — what's brand new, what's being talked about more, and what is spreading to more companies across the sector.

Unlock themes

Ask about Thermo Fisher Scientific's earnings, or other S&P 500 earnings calls

Ask across the corpus, instead of reading one call at a time. Scope it to Thermo Fisher Scientific, its sector, or every name we cover — plain English, no operators — and answers come back structured: a summary, the drivers, and a read on each company.

"What did Thermo Fisher Scientific say about margins, and did the framing change from last quarter?"

"Did Thermo Fisher Scientific's management walk back any full-year guidance, and how did they frame it?"

"Where did Thermo Fisher Scientific avoid answering on capital allocation?"

Unlock search

Earnings call history & sentiment

Every one at 08:30 ET, before the open.

Date Day Period Corpusense read
2026-07-23Thursday2026 Q3Positive
2026-04-23Thursday2026 Q2—
2026-01-29Thursday2026 Q1—
2025-10-22Wednesday2025 Q4—
2025-07-23Wednesday2025 Q3—
2025-04-23Wednesday2025 Q2—
2025-01-30Thursday2025 Q1—

Earnings calls across Life Sciences Tools & Services

The companies Thermo Fisher Scientific is read alongside. Each has its own earnings call dates and sentiment.

AAgilent TechnologiesCRLCharles River LaboratoriesDHRDanaher CorporationIQVIQVIAMTDMettler ToledoTECHBio-TechneWATWaters Corporation

Thermo Fisher Scientific is one of the S&P 500 companies we track

Sentiment analysis on any single earnings call, themes building across a sector, and search across every company and quarter — each claim linked back to the passage it came from.

Create a free account See the full calendar Plans & pricing